SAN FRANCISCO & PALO ALTO, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat clinicians and patients, today reported data from its pivotal ...

The acquisition will allow Intersect ENT’s portfolio to support routine and complex procedures and positions the company to serve the growing market for ENT services, the statement said. It will also ...

Staying true to its pledge to crack down on potentially anticompetitive megamergers in the healthcare industry, the U.S. Federal Trade Commission has ordered Medtronic and Intersect ENT to adjust the ...

Intersect ENT has announced it has received FDA approval of the company’s second steroid-releasing product, according to a news release (pdf). The PROPEL mini is designed for localized drug delivery ...

Intersect ENT, Inc.’s XENT long-term prospects, driven by the favorable chronic sinusitis market, encourage us. However, the business has been severely hit by low ENT office visits amid COVID-19. The ...

Medtronic said Friday that it has closed on a deal to acquire California-based Intersect ENT, one day after the Federal Trade Commission said the acquisition could move forward only if Medtronic ...

It may have taken an order from the Federal Trade Commission to get there—and Medtronic may be getting less bang for its buck than initially expected—but the medtech giant’s acquisition of Intersect ...